Evidence map›Paper›PMID 29750501›Full record

ArticleACS synthetic biology2018

Synthetic Toolkit for Complex Genetic Circuit Engineering in Saccharomyces cerevisiae.

Anssi Rantasalo, Joosu Kuivanen, Merja Penttilä, Jussi Jäntti, Dominik Mojzita

Open access · hybridAbstract read
In one paragraph

Article in ACS synthetic biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. The switch-liker's guide to plant synthetic gene circuits.The Plant journal : for cell and molecular biology · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Cyanamide-inducible expression of homing nucleaseSynthetic and systems biotechnology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. RNAi-based Boolean gates in the yeastFrontiers in bioengineering and biotechnology · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anssi RantasaloVTT Technical Research Centre of Finland Ltd. , P.O. Box 1000, FI-02044 VTT Espoo , Finland.
Joosu KuivanenVTT Technical Research Centre of Finland Ltd. , P.O. Box 1000, FI-02044 VTT Espoo , Finland.
Merja PenttiläVTT Technical Research Centre of Finland Ltd. , P.O. Box 1000, FI-02044 VTT Espoo , Finland.
Jussi JänttiVTT Technical Research Centre of Finland Ltd. , P.O. Box 1000, FI-02044 VTT Espoo , Finland.
Dominik MojzitaVTT Technical Research Centre of Finland Ltd. , P.O. Box 1000, FI-02044 VTT Espoo , Finland.ORCID 0000-0001-6078-4503
VTT Technical Research Centre of Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sustainable production of chemicals, materials, and pharmaceuticals is increasingly performed by genetically engineered cell factories. Engineering of complex metabolic routes or cell behavior control systems requires robust and predictable gene expression tools. In this challenging task, orthogonality is a fundamental prerequisite for such tools. In this study, we developed and characterized in depth a comprehensive gene expression toolkit that allows accurate control of gene expression in Saccharomyces cerevisiae without marked interference with native cellular regulation. The toolkit comprises a set of transcription factors, designed to function as synthetic activators or repressors, and transcription-factor-dependent promoters, which together provide a broad expression range surpassing, at high end, the strongest native promoters. Modularity of the developed tools is demonstrated by establishing a novel bistable genetic circuit with robust performance to control a heterologous metabolic pathway and enabling on-demand switching between two alternative metabolic branches.

Indexed as

Gene Regulatory NetworksGene Expression Regulation, FungalGenetic EngineeringIndolesMetabolic Networks and PathwaysMicroorganisms, Genetically-ModifiedPromoter Regions, GeneticRepressor ProteinsSaccharomyces cerevisiaeTranscription FactorsIndolesRepressor ProteinsTranscription Factorsviolaceinbistable switchcore promotergene regulationsynthetic transcription factoryeast

Identifiers

PMID29750501
PMCPMC6150731
OpenAlexW2800638982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.